Drugs · Entity Annotation Prototype (beta)

3articles mentioning drugs

19drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: OBZ ×

OBZ

This drug is selected. Its supporting articles are shown below.

OBZ3

Articles mentioning OBZ

3 articles · page 1 of 1

Comparison of obinutuzumab and rituximab for treating neuropsychiatric lupus: a retrospective case-control study

lupusscimed · abstract · 2025-11-04 · 8 matching annotations

92.8%

rituximab obinutuzumab OBZ RTX Shanghai Jiao Tong University School of Medicine

…the effectiveness and safety profiles of obinutuzumab (OBZ) and rituximab (RTX) in patients with NPSLE.Methods Patients with new-onset NP…

PO:12:322 Obinutuzumab experience in systemic lupus erythematosus patients: case series

lupusscimed · abstract · 2026-03-01 · 7 matching annotations

95.5%

OBZ SLEDAI-2K RTX RTX-refractory RTX-RTX lupus nephritis Istanbul University-Cerrahpasa SLE

… this small real-world cohort of RTX-refractory/intolerant SLE, OBZ yielded promising responses, including in lupus nephritis, with…

PO:11:282 Remarkable efficacy of obinutuzumab in refractory lupus nephritis: preliminary, real world data from a multicenter register

lupusscimed · abstract · 2026-03-01 · 4 matching annotations

86.4%

hydroxychloroquine belimumab rituximab Obinutuzumab prednisone mycophenolate mophetil OBZ MMF/Na lupus nephritis refractory LN+1 more

…sant; 3/5 rituximab and 4/5 belimumab. Concomitant therapy: 5/5 hydroxychloroquine, 4/5 MMF/Na, 5/5 prednisone (mean baseline dose 15 mg/day (10-1…